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Abstract
Background: This study investigated the relationships among salivary stress biomarkers, cigarette smoking, and
mood states.
Methods: The study population comprised 49 healthy sixth-year dental students at Fukuoka Dental College (39
men, 10 women; age, 23–31 years). Lifetime exposure to smoking was calculated using the Brinkman index (BI).
Resting saliva samples were collected, and concentrations of cortisol, secretory immunoglobulin A (SIgA), interleukin
(IL)-1β, interleukin-6, and tumor necrosis factor (TNF)-α were determined. Mood states (tension-anxiety,
depression-dejection, anger-hostility, fatigue, confusion, and vigor) over the previous week were assessed using the
Profile of Mood States - Brief Japanese Version.
Results: Salivary IL-1β levels were significantly higher in smokers than non-smokers (P = 0.044), regardless of the BI
or mood state. A significant positive correlation was evident between the TNF-α level and the BI (P = 0.036), and the
SIgA level was positively correlated with the BI (P = 0.067) but did not reach statistical significance. In terms of
mood states, higher fatigue scores and lower vigor scores were observed in smokers. The TNF-α level and vigor
score were negatively correlated (r = –0.229, P = 0.135), but the correlation did not reach statistical significance.
However, the SIgA level and fatigue score were significantly positively correlated (r = 0.410, P = 0.005).
Conclusions: The TNF-α and SIgA levels were both positively correlated with the BI. Furthermore, the TNF-α level
was negatively correlated with the vigor score, whereas the SIgA level was positively correlated with the fatigue
score. Thus, salivary levels of TNF-α and SIgA may be used as biomarkers of mood states in healthy young smokers.
Keywords: Cigarette smoking, Interleukin-1β, Profile of mood states, Secretory immunoglobulin A, Salivary stress
markers, Tumor necrosis factor-α
Background
Smokers generally indicate that stress relief and relax-
ation are their main reasons for smoking [1, 2]. Previous
experimental studies have found that cigarette craving is
increased after acute stress exposure in smokers [3, 4].
Furthermore, an increased rate of smoking is reported
after large-scale disasters, such as terrorist attacks, hurri-
canes, and fires [5–7]. On the other hand, chronic
exposure to nicotine is thought to increase subjective
stress levels and exacerbate a depressed mood by indu-
cing changes in neurotransmitter systems and neural
pathways implicated in mood regulation. Associations
between smoking and negative moods, symptoms of
terminal insomnia, and psychiatric disorders have been
reported in clinical and epidemiologic studies [8–10].
The hypothalamic-pituitary-adrenal (HPA) and
sympathetic-adrenal-medullary (SAM) axes are the
two main stress response pathways in the human
body. In addition to these axes, a link between the
immune system and stress has been reported recently
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[11]. Bidirectional communication between the HPA axis
and immune system plays a key role in the response to
chronic and repeated stressors. Cortisol, which is an
effector of the HPA axis, increases after nicotine adminis-
tration and decreases in response to acute tobacco abstin-
ence [12, 13]. In the context of chronic stress, salivary
cortisol levels are higher in depressed individuals, com-
pared to non-depressed individuals [14]. The effect of
smoking-associated chronic stress on salivary cortisol pro-
duction is unclear. The glycoprotein secretory immuno-
globulin A (SIgA) participates in the acquired immune
response. Under acute stress, the SIgA levels in saliva
change in association with cortisol levels [15]. By contrast,
other research suggests an inverse association between
SIgA and cortisol following psychological stress [16]. Sal-
ivary SIgA levels are generally recognized to decrease in
response to chronic stress, but increase in response to
acute stress. There are various reports on the relationship
between cigarette smoking and salivary SIgA. Some stud-
ies have reported lower levels of salivary SIgA in smokers,
compared to non-smokers [17, 18]. However, another
study reported increased levels of SIgA in the saliva of
immunocompetent smokers [19]. Proinflammatory cyto-
kines, including interleukin (IL)-1β, interleukin (IL)-6, and
tumor necrosis factor (TNF)-α, which increase during
early inflammation, are believed to activate the HPA axis
[20]. The effects of cigarette smoking on the levels of these
cytokines in gingival crevicular fluid (GCF) have been
researched extensively in relation to periodontitis [21].
Some reports indicate that high levels of these cytokines
are observed in the GCF of smokers [22, 23]. Conversely,
the GCF level of IL-1β levels at deep bleeding sites were
reported to be lower in smokers than in non-smokers
[24]. In another study, the TNF-α levels in the GCF were
found to be higher in smokers than in non-smokers, al-
though smoking was not associated with differing levels of
IL-6 in the GCF [25]. There are few reports of the use of
salivary cytokines to evaluate the effects of smoking on
the immune response in healthy participants.
In this study, we investigated the relationship between
the levels of five salivary stress biomarkers (cortisol,
SIgA, IL-1β, IL-6, and TNF-α) and cigarette smoking in
healthy young adults. Furthermore, the relationship be-
tween salivary biomarker levels and mood states related
to cigarette smoking was explored.
Methods
Study population
The study population consisted of 49 subjects (39
men, 10 women; mean age, 25.6 ± 2.1 years; range,
23–31 years) who were healthy sixth-year dental stu-
dents at Fukuoka Dental College. Of the 51 students
assigned to participate in the study, 1 student refused
to participate and another student did not provide
sufficient resting saliva for analysis. Therefore, 49 stu-
dents participated in the study. Approval of this study
was obtained from the Ethics Committee for Clinical
Research at Fukuoka Dental College and Fukuoka
College of Health Sciences (Approval No. 249). All
participants understood the nature of the research
project, and provided written informed consent to
participate in this study.
Samples were collected in June 2014. No problems
were found for any participant in dental and health
checkups performed in April 2014. No participant had
taken antibiotics for at least the past 3 months. The
smoking status of the participants was obtained by a
self-completed questionnaire. Smoking status was de-
fined in the questionnaires as “smokers”, individuals
who had smoked ≥100 cigarettes in total after starting
smoking and “non-smokers”, individuals who had never
smoked or smoked <100 cigarettes in total after starting
smoking [26]. Lifetime exposure to smoking was calcu-
lated using the Brinkman index (BI), which is defined as
(number of cigarettes per day) × (number of years for
which a person smoked) [27].
Collection of saliva, and determination of cortisol, SIgA,
IL-1β, IL-6, and TNF-α concentrations
Participants were asked to collect 3 mL of resting whole
saliva in a disposable plastic tube at 3:30 pm at least
2.5 h after eating, smoking, or brushing their teeth. The
saliva samples were stored at –30 °C until biomarker
concentrations were measured.
The concentrations of salivary stress biomarkers were
determined using enzyme-linked immunosorbent assays
(ELISAs). The cortisol and SIgA concentrations were
quantified by competitive immunoassays using the Cor-
tisol ELISA kit and Secretory Immunoglobulin A ELISA
kit, respectively (Salimetrics LLC, State College, PA,
USA). IL-1β, IL-6, and TNF-α concentrations were
quantified by sandwich ELISA, using the Human IL-1β
ELISA, Human IL-6 ELISA, and Human TNF-α ELISA
kits, respectively (Diaclone, Besançon Cedex, France).
Mood assessment
Mood states over the previous week were assessed using
the Profile of Mood States (POMS) - Brief Japanese
Version (Kaneko Publishing, Tokyo, Japan). The POMS
short form evaluates moods on six subscales (Tension-
Anxiety, Depression-Dejection, Anger-Hostility, Fatigue,
Confusion, and Vigor) in a short time [28]. The instru-
ment contains 30 items that are rated on a 5-point scale
from 0 (not at all) to 4 (extremely). Elementary scores
were converted to T scores according to the sex- and age-
specific table that was provided by the manufacturer. Each
T score was calculated as follows: 50 + 10 × (elementary
score – average)/standard deviation.
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Statistical analysis
The t-test and χ2 test were used to compare demo-
graphic and mood state data between smokers and non-
smokers. Linear regression analysis, adjusted for age,
was used to compare the concentrations of salivary
stress biomarkers between smokers and non-smokers.
Partial correlation coefficients were calculated to evalu-
ate the relationships among salivary stress biomarker
levels, BI, and age and among salivary stress biomarker
levels, mood state, and age. All statistical analyses were
performed using SPSS software (version 22.0; SPSS
Japan, Tokyo, Japan). A P value of <0.05 was considered
statistically significant.
Results
There were 18 smokers and 31 non-smokers. The
smoker group comprised 17 current smokers and one
ex-smoker who had stopped smoking 1 year prior. The
average age of the smokers (26.8 ± 2.4 years [± SD]) was
significantly greater than that of the non-smokers (25.0
± 1.6 years [± SD]) (P = 0.005). The proportions of
women were 11.1 % (2/18) in the smoker group and
25.8 % (8/31) in the non-smoker group, with no signifi-
cant difference between the two groups (P = 0.219).
Figure 1 compares salivary stress biomarkers be-
tween the smokers and non-smokers after adjusting
for age. The concentrations (median [IQR]) of IL-1β
were significantly (P = 0.044) higher in the smokers than
non-smokers (271.3 [81.0–385.2] vs. 74.2 [44.6–131.6]
pg/mL, respectively). Although the concentrations of
SIgA (54.4 [47.1–66.3] vs. 52.7 [45.3–64.7] μg/mL) and
TNF-α (13.7 [8.90–23.3] vs. 12.5 [7.82–17.9] pg/mL) were
slightly higher in the smokers compared to the non-
smokers, the differences were not significant. The cortisol
and IL-6 concentrations in saliva did not differ between
the two groups. The range of IL-6 levels was greater in the
non-smokers than in the smokers.
Subsequently, the relationships between the concen-
trations of salivary stress biomarkers and the BI were an-
alyzed after adjusting for age. The median [IQR] BI in
the smokers was 150 [58.8–207.5]. Figure 2 summarizes
the correlations between salivary stress biomarkers and
the BI in all participants, with the BI of non-smokers set
to 0. TNF-α concentrations had a significantly positive
correlation with BI values (r = 0.303, P = 0.036). There
was a weak positive correlation trend between the con-
centration of SIgA concentrations and the BI value (r =
0.267, P = 0.067), but statistical significance was not ob-
served. The other salivary biomarkers showed no correl-
ation with BI values.
Analysis of the mood states obtained from the
POMS showed higher fatigue scores (P = 0.047) and
lower vigor scores (P = 0.017) in the smokers com-
pared to the non-smokers (Table 1). In addition, the
scores for depression-dejection, anger-hostility, and
confusion were higher in the smokers compared to
the non-smokers, but without statistical significance.
The correlations among salivary biomarkers, the
mood states of vigor and fatigue related to smoking,
and age were explored (Table 2). TNF-α levels
showed a weak non-significant negative correlation
with vigor (r = –0.229, P = 0.135). SIgA levels showed





Fig. 1 Comparison of the levels of salivary stress biomarkers between smokers and non-smokers: cortisol (a), SIgA (b), IL-1β (c), IL-6 (d), and TNF-α
(e). *P < 0.05 by linear regression analysis after adjusting for age
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Discussion
Salivary cytokines are produced during periodontal in-
flammation and tissue destruction. Smoking also in-
creases cytokine levels in the saliva and gingival
crevicular fluid, accelerates inflammation, and destroys
periodontal tissue. Therefore, many studies have focused
on the effect of smoking on cytokines in periodontitis,
and adult participants, including middle-aged and older
people, have generally been targeted. In our current
work, we studied periodontally healthy young adults to
avoid the effects of the periodontal conditions on the
saliva biomarker concentrations. The primary findings of
this study were that salivary IL-1β is associated with ac-
tive smoking, independent of the amount smoked, and
that salivary TNF-α levels positively correlate with the
amount smoked.
The median IL-1β concentration was 3.6 times higher
in the smokers (271 pg/mL) than in the non-smokers
(74 pg/mL) in this study. A study on ≥30-year-old par-





Fig. 2 Correlation between salivary stress biomarker levels and the Brinkman index after adjusting for age: cortisol (a), SIgA (b), IL-1β (c), IL-6 (d),
and TNF-α (e). R: partial correlation coefficient. The TNF-α level and the Brinkman index were positively correlated (P = 0.036). The SIgA level was
weakly positively correlated with the Brinkman index, but statistical significance was not attained (P = 0.067)
Table 1 Mood states, as evaluated using the POMS (T scores,
mean ± SD)
POMS scale Non-smokers (n = 31) Smokers (n = 18)
Tension-Anxiety 54.2 ± 12.4 52.3 ± 12.3
Depression-Dejection 51.2 ± 11.1 57.0 ± 11.9
Anger-Hostility 49.1 ± 9.8 51.0 ± 11.7
Vigor* 46.8 ± 12.5 39.9 ± 6.5
Fatigue* 54.2 ± 14.0 61.9 ± 11.7
Confusion 57.2 ± 13.1 59.7 ± 10.5
POMS Profile of Mood States
*P < 0.05 between smokers and non-smokers according to the t-test
Table 2 Partial correlation coefficients between salivary stress
biomarkers, mood states of vigor and fatigue, and age







aA weak negative correlation was evident between the TNF-α level and vigor,
but statistical significance was not attained (P = 0.135)
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IL-1β concentration was higher in smokers (706 pg/mL)
than in non-smokers (612 pg/mL) [29]. Also, in the peri-
odontally healthy control group of the cited study, the
mean IL-1β concentration was slightly higher in smokers
(479 pg/mL) than in non-smokers (464 pg/mL), but the
difference was not significant [29]. Overall, there are few
data on the effect of smoking on salivary IL-1β levels
in periodontally healthy populations. The effects of
smoking on salivary IL-1β production are diverse
across the whole population. A cross-sectional study
in adults (20–89 years) reported that IL-1β levels were
significantly higher in participants with periodontitis
(144 pg/mL) compared to healthy participants (61 pg/mL),
but there was no difference in salivary IL-1β concentrations
between smokers (52 pg/mL) and non-smokers (78 pg/mL)
[30]. An analysis of salivary cytokines in workers age 18–62
years found that the mean salivary IL-1β level was signifi-
cantly higher in passive smokers (190 pg/mL) than in non-
smokers (164 pg/mL), but no significant difference was
found between passive and active smokers (167 pg/mL)
[31]. Furthermore, levels of other biomarkers, such as pros-
taglandin E2, matrix metalloproteinase-9, lactoferrin, albu-
min, and aspartate aminotransferase were significantly
lower in active smokers [31]. Based on these data, smoking
may have the potential to suppress the host-defense system
and promote periodontal disease progression. The effects
of smoking on salivary cytokines likely vary widely with age,
host-defense system characteristics, and the progression of
periodontitis. Aging is characterized by qualitative and
quantitative changes in the immune system (i.e., increased
levels of pro-inflammatory cytokines and reduced levels of
anti-inflammatory cytokines [32]). Therefore, the age of the
study participants may have affected the biomarker levels.
The age range of the participants was narrow (23–31 years);
therefore, the observed effect of smoking on salivary IL-1β
levels is likely to be real, although the age of smokers was
significantly higher than that of non-smokers.
In this study, salivary TNF-α concentrations were
positively correlated with the amount smoked. Our
result is consistent with studies that examined the
TNF-α levels in serum and in exhaled breath conden-
sate [33, 34]. Analysis of exhaled breath condensate
TNF-α concentrations revealed that smokers had
higher TNF-α concentrations, compared to non-
smokers [33]. Petrescu et al. [34] reported that the
serum TNF-α levels were significantly higher in a
group of smokers compared to a group of non-
smokers. They also noticed increased TNF-α concen-
trations in the serum of smokers that smoked more
than one pack per day compared with those who
smoked less than one pack per day. The high concen-
tration of TNF-α in smokers is understood to reflect
smoke-induced lung injuries and is considered a use-
ful biomarker for the identification of heavy smokers
with a high risk of developing smoke-induced pul-
monary diseases.
TNF-α concentrations also correlated weakly in a
negative manner with vigor scores, which were lower in
smokers than in non-smokers. Proinflammatory cyto-
kines (TNF-α, IL-1β, and IL-6) stimulate the HPA axis,
promoting the secretion of corticotropin releasing factor,
which may be one mechanism by which inflammation
induces depressive symptoms [35]. In addition, TNF-α is
believed to trigger depressive symptoms through the ac-
tivation of neuronal serotonin transporters and the
stimulation of indoleamine 2,3-dioxygenase activity,
causing tryptophan depletion. [36]. Cavadini et al. [37]
reported that increased TNF-α and IL-1β levels impaired
clock gene functions and caused sleep disturbances and
fatigue in an in vivo assay using mice. A clinical study
that evaluated the effect of forest bathing found an in-
verse correlation between TNF-α levels and vigor scores
[38]. The high salivary TNF-α levels in the smokers ob-
served in this study could affect mental health.
Chronic stress suppresses salivary SIgA in general.
Contrary to expectations, salivary SIgA concentrations
showed a weak positive correlation with the amount of
smoking and a significant positive correlation with fa-
tigue scores. Norhagen and Engström [19] reported in-
creased SIgA levels in the saliva of immunocompetent
smokers, and suggested that this is indicative of an at-
tempt to protect the oral mucosa. Our study participants
were physically healthy, so our result might be related to
immune protection. Conversely, it has been reported
that acute psychological stress caused by a mock job
interview increased salivary SIgA levels in undergraduate
students [39]. Although a mental load test was not per-
formed in the current study, just before implementation,
the participants were informed of the requirement to
collect saliva and complete the POMS and smoking-
habit questionnaires. Those requirements might have re-
sulted in acute stress for smokers.
Our study had some design limitations. First, the aver-
age age of smokers was significantly higher than that of
nonsmokers, even though the age range of the study
participants was narrow. Therefore, the data in the stat-
istical analyses were adjusted for age. Second, few study
subjects were women. There were no differences in sal-
ivary biomarker levels between men and women (data
not shown). A previous study reported that the SIgA
concentration in young children was the same in males
and females [40]. However, another study recently re-
ported that SIgA levels in young healthy adults were
lower in females than males [41]. The effects of sex on
the statistical power and the generalizability of the study
results must be interpreted with caution. Finally, saliva
collection was performed at 15:30 and at least 2.5 h after
eating, smoking, or teeth brushing. Salivary biomarkers
Suzuki et al. Tobacco Induced Diseases  (2016) 14:20 Page 5 of 7
have distinctive circadian [42]. If a longitudinal study of
salivary biomarkers is conducted, it is important that sal-
iva collection be done at the same time and with the
same conditions.
Conclusions
This study examined physically and mentally healthy
young adults. IL-1β and TNF-α levels in saliva were as-
sociated with smoking, and analysis of the mood states
obtained from the POMS showed higher fatigue scores
and lower vigor scores in the smokers than the non-
smokers. In addition, a trend toward a negative relation-
ship was observed between TNF-α levels in saliva and
vigor scores. The salivary SIgA concentration was weakly
positively correlated with the extent of smoking, but was
significantly positively correlated with the fatigue score.
Salivary levels of TNF-α and SIgA may be useful bio-
markers of mood states in healthy young smokers.
Acknowledgements
This study was supported in part by Grants-in-Aid for Scientific Research
(nos. 26463203 and 26463175) from the Ministry of Education, Culture,
Sports, Science and Technology, Japan, and the MEXT-Supported Program
for the Strategic Research Foundation at Private Universities, 2012–2016.
Authors’ contributions
NS designed the study, analyzed the data, and wrote the manuscript. KN
and MY collected salivary samples and performed the salivary experiments.
They also collected the POMS and smoking status data of the study
population. T Hanioka and T Hirofuji commented on the data and assisted
with writing the manuscript. All authors read and approved the final version
of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Preventive and Public Health Dentistry, Fukuoka Dental
College, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan. 2Department of
General Dentistry, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku,
Fukuoka 814-0193, Japan.
Received: 6 September 2015 Accepted: 1 June 2016
References
1. Filder JA, West R. Self-perceived smoking motives and their correlates in a
general population sample. Nicotine Tob Res. 2009;11:1182–8.
2. McEwen A, West R, McRobbie H. Motives for smoking and their correlates in
clients attending Stop Smoking treatment services. Nicotine Tob Res.
2008;10:843–50.
3. Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann
US. Cigarette craving increases after a psychosocial stress test and is related
to cortisol stress responses but not to dependence scores in daily smokers.
J Psychopharmacol. 2010;24:247–55.
4. Perkins KA, Grobe JE. Increased desire to smoke during acute stress. Br J
Addict. 1992;87:1037–40.
5. Flory K, Hankin BL, Kloos B, Cheely C, Turecki G. Alcohol and cigarette use
and misuse among Hurricane Katrina survivors: psychosocial risk and
protective factors. Subst Use Misuse. 2009;44:1711–24.
6. Nandi A, Galea S, Ahern J, Vlahov D. Probable cigarette dependence, PTSD,
and depression after an urban disaster: results from a population survey of
New York City residents 4 months after September 11, 2001. Psychiatry.
2005;68:299–310.
7. Parslow RA, Jorm AF. Tobacco use after experiencing a major natural
disaster: analysis of a longitudinal study of 2063 young adults. Addiction.
2006;101:1044–50.
8. Bakhshaie J, Zvolensky MJ, Goodwin RD. Cigarette smoking and the onset
and persistence of depression among adults in the United States:
1994–2005. Compr Psychiatry. 2015;60:142–8.
9. Dierker L, Rose J, Selya A, Piasecki TM, Hedeker D, Mermelstein R.
Depression and nicotine dependence from adolescence to young
adulthood. Addict Behav. 2015;41:124–8.
10. Patten CA, Gillin JC, Golshan S, Wolter TD, Rapaport M, Kelsoe J.
Relationship of mood disturbance to cigarette smoking status among 252
patients with a current mood disorder. J Clin Psychiatry. 2001;62:319–24.
11. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the
hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral
Immunol. 2005;18:41–78.
12. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M,
Rao SM, Bandettini PA, Bloom AS. Nicotine-induced limbic cortisol activation in
the human brain: a functional MRI study. Am J Psychiatry. 1998;155:1009–15.
13. Wong JA, Pickworth WB, Waters AJ, al’Absi M, Leventhal AM. Cortisol levels
decrease after acute tobacco abstinence in regular smokers. Hum
Psychopharmacol. 2014;29:152–62.
14. Booij SH, Bos EH, Bouwmans ME, van Faassen M, Kema IP, Oldehinkel AJ, de
Jonge P. Cortisol and α-amylase secretion patterns between and within
depressed and non-depressed individuals. Plos One. 2015;10:e0131002.
15. Laurent HK, Stroud LR, Brush B, D’Angelo C, Granger DA. Secretory IgA
reactivity to social threat in youth: relations with HPA, ANS, and behavior.
Psychoneuroendocrinology. 2015;59:81–90.
16. Ng V, Koh D, Ong HY, Chia SE, Ong CN. Are salivary immunoglobulin A and
lysozyme biomarkers of stress among nurses? J Occup Environ Med.
1999;41:920–7.
17. Giuca MR, Pasini M, Tecco S, Giuca G, Marzo G. Levels of salivary
immunoglobulins and periodontal evaluation in smoking patients. BMC
Immunol. 2014;15:5.
18. Golpasand Hagh L, Zakavi F, Ansarifar S, Ghasemzadeh O, Solgi G.
Association of dental caries and salivary sIgA with tobacco smoking. Aust
Dent J. 2013;58:219–23.
19. Norhagen Engström G, Engström PE. Effects of tobacco smoking on salivary
immunoglobulin levels in immunodeficiency. Eur J Oral Sci. 1998;106:986–91.
20. Kunz-Ebrecht SR, Mohamed-Ali V, Feldman PJ, Kirschbaum C, Steptoe A.
Cortisol responses to mild psychological stress are inversely associated with
proinflammatory cytokines. Brain Behav Immun. 2003;17:373–83.
21. Ojima M, Hanioka T. Destructive effects of smoking on molecular and
genetic factors of periodontal disease. Tob Induc Dis. 2010;8:4.
22. Toker H, Akpıner A, Aydın H, Poyraz O. Influence of smoking on interleukin-
1beta level, oxidant status and antioxidant status in gingival crevicular fluid
from chronic periodontitis patients before and after periodontal treatment.
J Periodontal Res. 2012;47:572–7.
23. Kamma JJ, Giannopoulou C, Vasdekis VG, Mombelli A. Cytokine profile in
gingival crevicular fluid of aggressive periodontitis: influence of smoking
and stress. J Clin Periodontol. 2004;31:894–902.
24. Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW. Interleukin 1 and
receptor antagonist levels in gingival crevicular fluid in heavy smokers
versus non-smokers. J Clin Periodontol. 2003;30:42–8.
25. Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6
and TNF-α in periodontal disease. J Clin Periodontol. 1999;26:352–7.
26. Hanioka T, Ojima M, Tanaka K, Aoyama H. Relationship between smoking
status and tooth loss: findings from national databases in Japan. J
Epidemiol. 2007;17:125–32.
27. Brinkman GL, Coates Jr EO. The effect of bronchitis, smoking, and
occupation on ventilation. Am Rev Respir Dis. 1963;87:684–93.
28. Shacham S. A shortened version of the Profile of Mood States. J Pers Assess.
1983;47:305–6.
29. Gursoy UK, Könönen E, Uitto VJ, Pussinen PJ, Hyvärinen K, Suominen-Taipale
L, Knuuttila M. Salivary interleukin-1β concentration and the presence of
multiple pathogens in periodontitis. J Clin Periodontol. 2009;36:922–7.
30. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M,
Nouthashemi F. Proinflammatory cytokines, aging, and age-related diseases.
J Am Med Dir Assoc. 2013;14:877–82.
31. Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y,
Sorsa T, Gustafsson A. Salivary biomarkers of oral health–a cross-sectional
study. J Clin Periodontol. 2013;40:140–7.
Suzuki et al. Tobacco Induced Diseases  (2016) 14:20 Page 6 of 7
32. Nishida N, Yamamoto Y, Tanaka M, Maeda K, Kataoka K, Nakayama K,
Morimoto K, Shizukuishi S. Association between passive smoking and
salivary markers related to periodontitis. J Clin Periodontol. 2006;33:717–23.
33. Diez-Pina JM, Fernandez-Aceñero MJ, Llorente-Alonso MJ, Diaz-Lobato S,
Mayoralas S, Florez A. Tumor necrosis factor alpha as a marker of systemic
and local inflammation in “healthy” smokers. Int J Gen Med. 2009;2:9–14.
34. Petrescu F, Voican SC, Silosi I. Tumor necrosis factor-α serum levels in
healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis.
2010;5:217–22.
35. Blume J, Douglas SD, Evans DL. Immune suppression and immune
activation in depression. Brain Behav Immun. 2011;25:221–9.
36. Berthold-Losleben M, Himmerich H. The TNF-α system: functional aspects in
depression, narcolepsy and psychopharmacology. Curr Neuropharmacol.
2008;6:193–202.
37. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. TNF-α
suppresses the expression of clock genes by interfering with E-box-
mediated transcription. Proc Natl Acd Sci USA. 2007;104:12843–8.
38. Mao GX, Lan XG, Cao YB, Chen ZM, He ZH, Lv YD, Wang YZ, Hu XL, Wang
GF, Yan J. Effects of short-term bathing on human health in a broad-leaved
evergreen forest in Zhejiang Province, China. Biomed Environ Sci. 2012;25:
317–24.
39. Campisi J, Bravo Y, Cole J, Gobeil K. Acute psychological stress differentially
influences salivary endocrine and immune measures in undergraduate
students. Physiol Behav. 2012;107:317–21.
40. Avşar A, Darka O, Bodrumlu EH, Bek Y. Evaluation of the relationship
between passive smoking and salivary electrolytes, protein, secretory IgA,
sialic acid and amylase in young children. Arch Oral Biol. 2009;54:457–63.
41. Prodan A, Brand HS, Lightenberg AJ, Imangaliyav S, Tsivtsivadze E, van der
Weijden F, Crielaard W, Keijser BJ, Veerman EC. Eur J Oral Sci. 2015;123:149–
57.
42. Izawa S, Miki K, Liu X, Ogawa N. The diurnal patterns of salivary interleukin-6
and C-reactive protein in healthy young adults. Brain Behav Immun.
2013;27:38–41.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Suzuki et al. Tobacco Induced Diseases  (2016) 14:20 Page 7 of 7
